HK1005187A1 - Amide tetrazole acat inhibitors - Google Patents

Amide tetrazole acat inhibitors Download PDF

Info

Publication number
HK1005187A1
HK1005187A1 HK98104234A HK98104234A HK1005187A1 HK 1005187 A1 HK1005187 A1 HK 1005187A1 HK 98104234 A HK98104234 A HK 98104234A HK 98104234 A HK98104234 A HK 98104234A HK 1005187 A1 HK1005187 A1 HK 1005187A1
Authority
HK
Hong Kong
Prior art keywords
tetrazole
phenyl
dodecyl
acetamide
carbon atoms
Prior art date
Application number
HK98104234A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1005187B (en
Inventor
Michael O'brien Patrick
Armand Picard Joseph
Forsey Purchase Claude
David Roth Bruce
Robert Sliskovic Drago
David White Andrew
Original Assignee
沃纳-兰伯特公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 沃纳-兰伯特公司 filed Critical 沃纳-兰伯特公司
Publication of HK1005187B publication Critical patent/HK1005187B/en
Publication of HK1005187A1 publication Critical patent/HK1005187A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK98104234A 1991-08-22 1992-08-03 Amide tetrazole acat inhibitors HK1005187A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74856891A 1991-08-22 1991-08-22
US748568 1991-08-22
US91364392A 1992-07-20 1992-07-20
US913643 1992-07-20
PCT/US1992/006388 WO1993004052A1 (en) 1991-08-22 1992-08-03 Amide tetrazole acat inhibitors

Publications (2)

Publication Number Publication Date
HK1005187B HK1005187B (en) 1998-12-24
HK1005187A1 true HK1005187A1 (en) 1998-12-24

Family

ID=27114964

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104234A HK1005187A1 (en) 1991-08-22 1992-08-03 Amide tetrazole acat inhibitors

Country Status (20)

Country Link
EP (1) EP0600950B1 (cs)
JP (1) JP3113678B2 (cs)
KR (1) KR100221764B1 (cs)
AT (1) ATE144501T1 (cs)
AU (1) AU657790B2 (cs)
CA (1) CA2114017C (cs)
CZ (1) CZ281314B6 (cs)
DE (1) DE69214827T2 (cs)
DK (1) DK0600950T3 (cs)
ES (1) ES2093270T3 (cs)
FI (1) FI112221B (cs)
GR (1) GR3021942T3 (cs)
HK (1) HK1005187A1 (cs)
HU (1) HU221190B1 (cs)
MX (1) MX9204877A (cs)
NO (1) NO300632B1 (cs)
NZ (1) NZ244029A (cs)
PT (1) PT100804B (cs)
RU (1) RU2117664C1 (cs)
WO (1) WO1993004052A1 (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
US5239082A (en) * 1992-08-03 1993-08-24 Warner-Lambert Company Sulfonamide tetrazole ACAT inhibitors
US5461049A (en) * 1994-05-27 1995-10-24 Warner-Lambert Company Amide tetrazole ACAT inhibitors
US7531576B2 (en) 2000-12-26 2009-05-12 Pola Chemical Industries, Inc. Biphenyl derivatives
US7365199B2 (en) * 2001-04-20 2008-04-29 Fujifilm Corporation Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound
US7320967B2 (en) * 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
FR2845991B1 (fr) * 2002-10-16 2005-02-04 Pf Medicament Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
WO2005107758A1 (en) 2004-05-06 2005-11-17 Warner-Lambert Company Llc 4-phenylamino-quinazolin-6-yl-amides
US7598279B2 (en) * 2005-04-22 2009-10-06 Sk Holdings Co., Ltd. Neurotherapeutic azole compounds
US8501436B2 (en) * 2009-06-22 2013-08-06 Sk Biopharmaceuticals Co. Ltd. Method for preparation of carbamic acid (R)-1-aryl-2-tetrazolyl-ethyl ester
CN102153591B (zh) * 2011-01-17 2013-11-06 天津师范大学 2-(1h-四唑-5-甲基)吡啶和5-硝基间苯二甲酸混合配体锰(ii)配合物及制备方法与应用
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624097A (en) * 1969-07-22 1971-11-30 Warner Lambert Co N-pyridine 5-aminooxazoles
JPS5536447A (en) * 1978-09-07 1980-03-14 Otsuka Pharmaceut Co Ltd Butyramide derivative
US4871861A (en) * 1987-07-06 1989-10-03 Olin Corporation Substituted 5-amidotetrazoles
US5073565A (en) * 1990-04-27 1991-12-17 Warner-Lambert Company Tetrazole ureas and thioureas and their use as acat inhibitors

Also Published As

Publication number Publication date
AU657790B2 (en) 1995-03-23
DE69214827T2 (de) 1997-03-06
CZ36194A3 (en) 1994-07-13
HU9400491D0 (en) 1994-05-30
WO1993004052A1 (en) 1993-03-04
HU221190B1 (en) 2002-08-28
CZ281314B6 (cs) 1996-08-14
NZ244029A (en) 1995-09-26
MX9204877A (es) 1993-04-01
CA2114017A1 (en) 1993-03-04
EP0600950A1 (en) 1994-06-15
NO940596D0 (no) 1994-02-21
RU2117664C1 (ru) 1998-08-20
FI940731A0 (fi) 1994-02-16
JP3113678B2 (ja) 2000-12-04
ES2093270T3 (es) 1996-12-16
ATE144501T1 (de) 1996-11-15
FI940731A7 (fi) 1994-04-15
HUT70754A (en) 1995-10-30
DK0600950T3 (da) 1997-04-21
GR3021942T3 (en) 1997-03-31
PT100804B (pt) 1999-07-30
JPH06510040A (ja) 1994-11-10
PT100804A (pt) 1993-09-30
NO940596L (no) 1994-02-22
AU2414792A (en) 1993-03-16
DE69214827D1 (de) 1996-11-28
FI112221B (fi) 2003-11-14
NO300632B1 (no) 1997-06-30
KR100221764B1 (ko) 1999-09-15
CA2114017C (en) 2004-09-21
EP0600950B1 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
CA2155104C (en) Heterocyclic-substituted alkyl amide acat inhibitors
US5922724A (en) Benzimidazole compounds and their use as modulators of the GABA a receptor complex
US6706749B2 (en) Substituted phenyl derivatives, their preparation and use
KR101638671B1 (ko) 글루카곤 수용체 조절자
EP0600950B1 (en) Amide tetrazole acat inhibitors
EP1689713B1 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease
US5922725A (en) Benzimidazole compounds and their use as modulators of the GABAA receptor complex
HK1005187B (en) Amide tetrazole acat inhibitors
US5461049A (en) Amide tetrazole ACAT inhibitors
CN117362231A (zh) 一种取代脒类化合物的合成方法及其用途
US5239082A (en) Sulfonamide tetrazole ACAT inhibitors
JPS6299375A (ja) ベンゾジオキソ−ル誘導体
PL182101B1 (pl) Nowe pochodne acylowanych aminoalkanoimidazoli i srodek farmaceutyczny do selektywnego inhibitowania hydroksylaz 25-hydroksywitaminy D3 PL

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060803